title: [The disadvantage of large dose of cardioplegic solution and the effectiveness of ECUM].
authors.forename: H
authors.initials: H
authors.lastname: Kimura
authors.forename: S
authors.initials: S
authors.lastname: Shiguma
authors.forename: K
authors.initials: K
authors.lastname: Asada
authors.forename: M
authors.initials: M
authors.lastname: Maeda
authors.forename: H
authors.initials: H
authors.lastname: Ohmori
authors.forename: H
authors.initials: H
authors.lastname: Sato
authors.forename: R
authors.initials: R
authors.lastname: Koike
authors.forename: M
authors.initials: M
authors.lastname: Ozeki
authors.forename: S
authors.initials: S
authors.lastname: Sasaki
authors.forename: A
authors.initials: A
authors.lastname: Takeuchi
mesh_terms: D002315:Cardiopulmonary Bypass; D005947:Glucose / Q000008:administration & dosage / Q000009:adverse effects; D006331:Heart Diseases / Q000601:surgery; D006801:Humans; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects; D011188:Potassium / Q000008:administration & dosage / Q000009:adverse effects; D014462:Ultrafiltration / Q000379:methods*; D014883:Water-Electrolyte Imbalance / Q000209:etiology / Q000628:therapy*
chemical_list: D007328:Insulin; C030396:glucose-insulin-potassium cardioplegic solution; D005947:Glucose; D011188:Potassium